KA
Kintegral Advisory’s Idexx Laboratories IDXX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.94M | Sell |
5,483
-8
| -0.1% | -$4.29K | 0.27% | 98 |
|
2025
Q1 | $2.31M | Sell |
5,491
-19
| -0.3% | -$7.98K | 0.23% | 110 |
|
2024
Q4 | $2.28M | Sell |
5,510
-256
| -4% | -$106K | 0.22% | 117 |
|
2024
Q3 | $2.91M | Sell |
5,766
-76
| -1% | -$38.4K | 0.27% | 101 |
|
2024
Q2 | $2.85M | Buy |
5,842
+882
| +18% | +$430K | 0.27% | 99 |
|
2024
Q1 | $2.68M | Sell |
4,960
-15
| -0.3% | -$8.1K | 0.27% | 97 |
|
2023
Q4 | $2.76M | Sell |
4,975
-32
| -0.6% | -$17.8K | 0.31% | 91 |
|
2023
Q3 | $2.19M | Sell |
5,007
-3
| -0.1% | -$1.31K | 0.27% | 101 |
|
2023
Q2 | $2.52M | Hold |
5,010
| – | – | 0.3% | 96 |
|
2023
Q1 | $2.51M | Sell |
5,010
-269
| -5% | -$135K | 0.32% | 94 |
|
2022
Q4 | $2.15M | Buy |
5,279
+427
| +9% | +$174K | 0.28% | 106 |
|
2022
Q3 | $1.58M | Hold |
4,852
| – | – | 0.22% | 113 |
|
2022
Q2 | $1.7M | Buy |
4,852
+103
| +2% | +$36.1K | 0.22% | 107 |
|
2022
Q1 | $2.6M | Buy |
4,749
+106
| +2% | +$58K | 0.29% | 88 |
|
2021
Q4 | $3.06M | Hold |
4,643
| – | – | 0.32% | 78 |
|
2021
Q3 | $2.89M | Hold |
4,643
| – | – | 0.34% | 69 |
|
2021
Q2 | $2.93M | Hold |
4,643
| – | – | 0.35% | 70 |
|
2021
Q1 | $2.27M | Hold |
4,643
| – | – | 0.29% | 88 |
|
2020
Q4 | $2.32M | Hold |
4,643
| – | – | 0.32% | 79 |
|
2020
Q3 | $1.83M | Sell |
4,643
-149
| -3% | -$58.6K | 0.28% | 88 |
|
2020
Q2 | $1.58M | Hold |
4,792
| – | – | 0.25% | 95 |
|
2020
Q1 | $1.16M | Buy |
4,792
+537
| +13% | +$130K | 0.23% | 107 |
|
2019
Q4 | $1.11M | Hold |
4,255
| – | – | 0.2% | 128 |
|
2019
Q3 | $1.16M | Hold |
4,255
| – | – | 0.23% | 120 |
|
2019
Q2 | $1.17M | Hold |
4,255
| – | – | 0.24% | 119 |
|
2019
Q1 | $951K | Buy |
4,255
+2,081
| +96% | +$465K | 0.2% | 124 |
|
2018
Q4 | $404K | Buy |
+2,174
| New | +$404K | 0.12% | 150 |
|